Ph.D., health policy and administration, the University of North Carolina at Chapel Hill; M.D., Peking Union Medical College
Summary of Experience
Dr. Xie is a health economist with extensive experience in health economics and outcomes research. Her expertise includes economic evaluations, health technology assessments in both the U.S. and global markets, and comparative outcomes research using clinical trial and real-world data. She has worked in a variety of disease areas, such as mental health, oncology, cardiovascular and other chronic diseases, as well as infectious diseases. Her work has been widely published in leading clinical, economic, and managed care journals, including Circulation, Stroke, PharmacoEconomics, Value in Health, and American Journal of Managed Care. Dr. Xie has extensive experience in emerging markets, particularly in China. Her work in this area includes outcomes research using high-quality EMR data, economic evaluations, market access of oncology drugs, burden of illness based on claims and surveys, and the China National Stroke Registry design and revision of the treatment guidelines for hypertension and diabetes. She was a coeditor of PharmacoEconomics journal's special issue on health care in China. She also serves as an adjunct professor at Shanghai Jiao Tong University School of Public Health. Prior to joining Analysis Group, Dr. Xie was a health service researcher at the Centers for Disease Control and Prevention, leading the health services and outcomes research in the Division for Heart Disease and Stroke Prevention.